ABT vs RELL · P/E 25, rev $44.33B vs rev $51.9M
Abbott Laboratories (ABT) versus Richardson Electronics Ltd (RELL) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Richardson Electronics Ltd (RELL) is a electronic components company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported RELL revenue for 2025-05-31 was $51.9M. Net income was -$1.1M. Revenue was down 3.6% from 2025-03-01 to 2025-05-31. RELL currently screens at market cap $141.1M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. RELL currently screens at market cap $141.1M.
Not investment advice. Open the ABT and RELL stock pages for the full models.
Not investment advice.